Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| EPHA5 | P54756 | Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) | 1 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| EPOR | P19235 | Erythropoietin receptor (EPO-R) | 1 | AnemiaDepressionGeneral pain disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | |||
| ERBB3 | P21860 | Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3) | Cancer-related genesDisease related genesEnzymes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | |||
| FCAR | P24071 | Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Diabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | ||
| FCGR1 | P12314 | High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64) | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | ||||
| GLDN | Q6ZMI3 | Gliomedin [Cleaved into: Gliomedin shedded ectodomain] | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Other mediation | 1 | 0.38 | |||
| I13R2 | Q14627 | Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2) | 1 | AsthmaBrain cancerOesophagitis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | |||
| IL1R1 | P14778 | Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)] | Cancer-related genesCD markersEnzymes | 1 | Rheumatoid arthritisCOVID-19 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | ||
| IL4RA | P24394 | Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)] | Cancer-related genesCD markersFDA approved drug targets | 1 | AsthmaAtopic eczemaIdiopathic interstitial pneumonitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | ||
| IL7RA | P16871 | Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127) | Cancer-related genesCD markersDisease related genes | 1 | Atopic eczemaDiabetes mellitusHuman immunodeficiency virus disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | ||
| ITA9 | Q13797 | Integrin alpha-9 (Integrin alpha-RLC) | Human disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | |||
| KCNQ1 | P51787 | Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Hypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | ||
| KCNS3 | Q9BQ31 | Delayed-rectifier potassium channel regulatory subunit KCNS3 (Delayed-rectifier K(+) channel alpha subunit 3) (Delayed-rectifier potassium channel subunit Kv9.3) (Kv9.3) (Potassium voltage-gated channel subfamily S member 3) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.38 | |||
| KLRF1 | Q9NZS2 | Killer cell lectin-like receptor subfamily F member 1 (Lectin-like receptor F1) (Activating coreceptor NKp80) (C-type lectin domain family 5 member C) | 1 | Immune mediation | 1 | 0.38 | ||||
| NALCN | Q8IZF0 | Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) | Disease related genesHuman disease related genesMetabolic proteins | 24 | Fusion and delivery mediation | 1 | 0.38 | |||
| NECT2 | Q92692 | Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin cell adhesion molecule 2) (Poliovirus receptor-related protein 2) (CD antigen CD112) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | |||
| NECT4 | Q96NY8 | Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4] | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Bladder cancerSolid tumour/cancerUreteral cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | ||
| NINJ2 | Q9NZG7 | Ninjurin-2 (Nerve injury-induced protein 2) | 2 | Other mediation | 1 | 0.38 | ||||
| NOTC3 | Q9UM47 | Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Lung cancerPancreatic cancer | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.38 | ||
| NPTN | Q9Y639 | Neuroplastin (Stromal cell-derived receptor 1) (SDR-1) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationImmune mediationMetabolism mediation | 1 | 0.38 | |||
| NRCAM | Q92823 | Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related) | Disease related genesPlasma proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.38 | |||
| NRP2 | O60462 | Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2) | Cancer-related genesPlasma proteinsPredicted membrane proteins | 1 | Sarcoidosis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.38 | ||
| NRSN1 | Q8IZ57 | Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa) (Vesicular membrane protein p24) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 2 | Fusion and delivery mediation | 1 | 0.38 | |||
| OBRG | O15243 | Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein) (OB-RGRP) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 4 | Acute diabete complicationAlzheimer diseaseCachexia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.38 | ||
| PCDB1 | Q9Y5F3 | Protocadherin beta-1 (PCDH-beta-1) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 1 | 0.38 |